MorphoSys AG at JPMorgan Healthcare Conference Transcript
Good afternoon. I'm James Gordon, JPMorgan European pharma biotech analyst, and today, I've got the pleasure of introducing the MorphoSys presentation. So you're going to hear from MorphoSys' CEO, Jean-Paul Kress, and we're going to have a breakout after this in the Yorkshire Room, so I hope you can join us for the Q&A then.
So with that said, thank you very much for joining us. And I look forward to the presentation.
Thanks, James. Good afternoon. Pleasure to be here and to share with you our great progress at MorphoSys. These are very exciting times for us at MorphoSys as we are very well positioned for success and value creation. So our forward-looking statement slide.
A few years ago, we initiated a transformation from a leading technology provider deeply rooted in science to a fully integrated biopharma company in command of the whole value chain and focusing on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |